HEADER HYDROLASE/HYDROLASE INHIBITOR 07-MAY-07 2PSX TITLE CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: KALLIKREIN-5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: STRATUM CORNEUM TRYPTIC ENZYME, KALLIKREIN-LIKE PROTEIN 2, COMPND 6 KLK-L2; COMPND 7 EC: 3.4.21.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: LEUPEPTIN; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KLK5; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: ACTINOMYCETES STREPTOMYCES ROSEUS MA 839-A1; SOURCE 10 ORGANISM_TAXID: 66430; SOURCE 11 OTHER_DETAILS: CHEMICALLY SYNTHESIZED. KEYWDS ZINC INHIBITION, STRATUM CORNEUM, GLCOSYLATION, HYDROLASE, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.DEBELA,W.BODE,P.GOETTIG REVDAT 8 30-OCT-24 2PSX 1 REMARK REVDAT 7 30-AUG-23 2PSX 1 REMARK HETSYN REVDAT 6 29-JUL-20 2PSX 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 13-JUL-11 2PSX 1 VERSN REVDAT 4 24-FEB-09 2PSX 1 VERSN REVDAT 3 30-OCT-07 2PSX 1 JRNL REVDAT 2 18-SEP-07 2PSX 1 SOURCE REVDAT 1 11-SEP-07 2PSX 0 JRNL AUTH M.DEBELA,P.GOETTIG,V.MAGDOLEN,R.HUBER,N.M.SCHECHTER,W.BODE JRNL TITL STRUCTURAL BASIS OF THE ZINC INHIBITION OF HUMAN TISSUE JRNL TITL 2 KALLIKREIN 5. JRNL REF J.MOL.BIOL. V. 373 1017 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17881000 JRNL DOI 10.1016/J.JMB.2007.08.042 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 454889.070 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 14047 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 709 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1991 REMARK 3 BIN R VALUE (WORKING SET) : 0.3260 REMARK 3 BIN FREE R VALUE : 0.3730 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 101 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.037 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1793 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 107 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.40000 REMARK 3 B22 (A**2) : 32.22000 REMARK 3 B33 (A**2) : -23.83000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.79000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.38 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.46 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.800 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.600 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.730 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.180 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.230 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 42.62 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : DRGCNS_NAG_PI.PAR REMARK 3 PARAMETER FILE 5 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : DRGCNS_NAG_PI.TOP REMARK 3 TOPOLOGY FILE 5 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PSX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042745. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0500 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14701 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.20200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2BDG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG-MONOMETHYL ETHER, 200 MM REMARK 280 AMMOMIUM SULFATE, 100 MM MES,10 MM LEUPEPTIN, PH 5.6, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 62.60950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.64200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 62.60950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 33.64200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE LEUPEPTIN IS COVALENTLY CONNECTED TO ACTIVE_SITE SER 195 OF THE REMARK 400 ENZYME TO FORM A HEMIACETAL. REMARK 400 REMARK 400 THE LEUPEPTIN IS OLIGOPEPTIDE, A MEMBER OF ENZYME INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: LEUPEPTIN REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 60 CE NZ REMARK 480 LYS A 145 CE NZ REMARK 480 LYS A 166 CD CE NZ REMARK 480 ARG A 174 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 186 CG CD CE NZ REMARK 480 ARG A 188 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 195 C AR7 B 2004 1.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 25 -8.75 71.27 REMARK 500 ASN A 38 57.71 -141.56 REMARK 500 CYS A 42 153.23 53.44 REMARK 500 PRO A 74A 19.71 -68.22 REMARK 500 HIS A 96 -38.30 -38.04 REMARK 500 HIS A 150 98.53 -160.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PSY RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE IS A DISCREPANCY IN THE NORINE AND PDB NUMBERING, AS NORINE REMARK 999 COUNTS ACE AND LEU TOGETHER AS ONE RESIDUE. SO THE DBREF WILL REMARK 999 REPORT 4 PDB RESIDUES MATCHING NORINE 3 RESIDUE DBREF 2PSX A 16 246 UNP Q9Y337 KLK5_HUMAN 67 293 DBREF 2PSX B 2001 2004 NOR NOR00487 NOR00487 1 3 SEQRES 1 A 227 ILE ILE ASN GLY SER ASP CYS ASP MET HIS THR GLN PRO SEQRES 2 A 227 TRP GLN ALA ALA LEU LEU LEU ARG PRO ASN GLN LEU TYR SEQRES 3 A 227 CYS GLY ALA VAL LEU VAL HIS PRO GLN TRP LEU LEU THR SEQRES 4 A 227 ALA ALA HIS CYS ARG LYS LYS VAL PHE ARG VAL ARG LEU SEQRES 5 A 227 GLY HIS TYR SER LEU SER PRO VAL TYR GLU SER GLY GLN SEQRES 6 A 227 GLN MET PHE GLN GLY VAL LYS SER ILE PRO HIS PRO GLY SEQRES 7 A 227 TYR SER HIS PRO GLY HIS SER ASN ASP LEU MET LEU ILE SEQRES 8 A 227 LYS LEU ASN ARG ARG ILE ARG PRO THR LYS ASP VAL ARG SEQRES 9 A 227 PRO ILE ASN VAL SER SER HIS CYS PRO SER ALA GLY THR SEQRES 10 A 227 LYS CYS LEU VAL SER GLY TRP GLY THR THR LYS SER PRO SEQRES 11 A 227 GLN VAL HIS PHE PRO LYS VAL LEU GLN CYS LEU ASN ILE SEQRES 12 A 227 SER VAL LEU SER GLN LYS ARG CYS GLU ASP ALA TYR PRO SEQRES 13 A 227 ARG GLN ILE ASP ASP THR MET PHE CYS ALA GLY ASP LYS SEQRES 14 A 227 ALA GLY ARG ASP SER CYS GLN GLY ASP SER GLY GLY PRO SEQRES 15 A 227 VAL VAL CYS ASN GLY SER LEU GLN GLY LEU VAL SER TRP SEQRES 16 A 227 GLY ASP TYR PRO CYS ALA ARG PRO ASN ARG PRO GLY VAL SEQRES 17 A 227 TYR THR ASN LEU CYS LYS PHE THR LYS TRP ILE GLN GLU SEQRES 18 A 227 THR ILE GLN ALA ASN SER SEQRES 1 B 4 ACE LEU LEU AR7 MODRES 2PSX ASN A 159 ASN GLYCOSYLATION SITE HET ACE B2001 3 HET AR7 B2004 11 HET NAG C 1 14 HET NAG C 2 14 HETNAM ACE ACETYL GROUP HETNAM AR7 AMINO{[(4S)-4-AMINO-5,5- HETNAM 2 AR7 DIHYDROXYPENTYL]AMINO}METHANIMINIUM HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 ACE C2 H4 O FORMUL 2 AR7 C6 H17 N4 O2 1+ FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 HOH *107(H2 O) HELIX 1 1 ALA A 55 ARG A 59 5 5 HELIX 2 2 SER A 164 TYR A 172 1 9 HELIX 3 3 PHE A 234 ASN A 245 1 12 SHEET 1 A 7 SER A 20 ASP A 21 0 SHEET 2 A 7 GLN A 156 SER A 161 -1 O CYS A 157 N SER A 20 SHEET 3 A 7 LYS A 135 GLY A 140 -1 N CYS A 136 O ILE A 160 SHEET 4 A 7 PRO A 198 CYS A 201 -1 O VAL A 200 N LEU A 137 SHEET 5 A 7 SER A 204 TRP A 215 -1 O GLN A 210 N VAL A 199 SHEET 6 A 7 GLY A 226 ASN A 230 -1 O VAL A 227 N TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 N PHE A 181 O TYR A 228 SHEET 1 B 7 GLN A 30 LEU A 35 0 SHEET 2 B 7 GLN A 39 HIS A 48 -1 O GLN A 39 N LEU A 35 SHEET 3 B 7 TRP A 51 THR A 54 -1 O LEU A 53 N VAL A 45 SHEET 4 B 7 MET A 104 LEU A 108 -1 O ILE A 106 N LEU A 52 SHEET 5 B 7 GLN A 81 PRO A 90 -1 N ILE A 89 O LEU A 105 SHEET 6 B 7 ARG A 64 LEU A 67 -1 N LEU A 67 O GLN A 81 SHEET 7 B 7 GLN A 30 LEU A 35 -1 N LEU A 34 O ARG A 64 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.04 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.02 SSBOND 3 CYS A 129 CYS A 232 1555 1555 2.04 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.04 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03 LINK ND2 ASN A 159 C1 NAG C 1 1555 1555 1.45 LINK C ACE B2001 N LEU B2002 1555 1555 1.33 LINK C LEU B2003 N AR7 B2004 1555 1555 1.33 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 CISPEP 1 ARG A 36 PRO A 37 0 -0.17 CISPEP 2 SER A 146 PRO A 147 0 0.29 CISPEP 3 TYR A 218 PRO A 219 0 -0.05 CRYST1 125.219 67.284 39.916 90.00 94.35 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007986 0.000000 0.000607 0.00000 SCALE2 0.000000 0.014862 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025125 0.00000